---
document_datetime: 2023-09-21 17:20:42
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/nuedexta-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: nuedexta-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 0.7513333
conversion_datetime: 2025-12-26 16:43:21.338359
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Nuedexta

Procedural steps taken and scientific information after the authorisation

<!-- image -->

| Application number   | Scope                                                                                                                                                                                                                                                                                                                                  | Opinion/ Notification 1 issued on Commission Decision Issued 2 / amended on no   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------|----------------------------------|-----------|
| IAIN/0005            | To delete the black symbol and explanatory statement for medicinal products that are subject to additional monitoring in the Product Information. C.I.12 - Inclusion or deletion of black symbol and explanatory statements for medicinal products in the list of medicinal products that are subject to additional monitoring product | 24/10/2014                                                                       | SmPC and PL                      |           |

<!-- image -->

Medicinal product no longer authorised

<!-- image -->

<div style="page-break-after: always"></div>

| PSUV/0003   | Periodic Safety Update                                                                                                                                                       | 10/07/2014   | n/a   | PRAC        |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-------------|
| IAIN/0002   | C.I.12 - Inclusion or deletion of black symbol and explanatory statements for medicinal products in the list of medicinal products that are subject to additional monitoring | 03/04/2014   |       | SmPC and PL |
| IAIN/0001   | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location              | 31/01/2014   | n/a   | authorised  |

<!-- image -->
